Dr Iqbal Malik is a consultant cardiologist, specialising in coronary artery disease and structural heart disease including PFO, ASD and the TAVI procedure.
He is director of structural heart disease and clinical lead for TAVI procedures at Imperial College Healthcare NHS Trust; where is also an honorary senior lecturer.
He also leads the West London Heart Attack Centre at Hammersmith Hospital and is on the Pan-London Heart Attack Group.
Dr Malik trains undergraduate medical students, post graduate doctors and consultants, and is also a proctor for PFO closure, paravalvular leak closure and TAVI procedures.
Here is some of Dr Malik’s recent coverage for OneWelbeck Heart Health:
Publication: Daily Express online (c: 56,508,202) https://www.express.co.uk/life-style/health/1284288/heart-attack-symptoms-early-signs-chest-tightness-breathlessness?utm_source=email&utm_medium=sengrid&utm_campaign=website Date: 21 May 2020
Publication: Wales online (c: 4,416,732) https://www.walesonline.co.uk/news/uk-news/heart-attack-signs-appear-months-18290030?utm_source=email&utm_medium=sengrid&utm_campaign=website Date: 21 May 2020
Publication: Nottingham Post (c: 1,115,819) https://www.nottinghampost.com/news/uk-world-news/heart-attack-signs-appear-months-4153512?utm_source=email&utm_medium=sengrid&utm_campaign=website Date: 21 May 2020
Publication: Derby Telegraph (c:892,439) https://www.derbytelegraph.co.uk/news/uk-world-news/heart-attack-signs-appear-months-4153512?utm_medium=sengrid&utm_campaign=website&utm_source=email Date: 21 May 2020
Dr Malik has a TopDoctors Gold Award. He also is regularly rated 5 star on Doctify. He has been awarded a clinical excellence award by the NHS.
He is actively involved in research, particularly coronary artery disease and structural heart disease. He has been involved in conducting many clinical trials, and was a founding member of the International Centre for Circulatory Health (ICCH) – a centre of research excellence at Imperial College London.
Dr Malik research interests are diabetes, heart attack, stroke, TAVI and also left atrial appendage closure. He also leads the Imperial Cardiovascular Simulation Training (iCAST) programme, with world-class immersive behavioural simulation to aid patient safety.
His current research is focused on interventional cardiology: the role of hole in the heart closure (PFO closure) in migraine and stroke, the prevention of angina and heart attacks using coronary angioplasty (PCI, or PTCA and STENTS) and surgery. To see Dr Malik performing a PFO closure, watch this video on YouTube.
Dr Malik is also part of the largest trial in TAVI ever done in the UK: BHF-PROTECT-TAVI, to assess if we can reduce stroke risk in TAVI procedures. He is on the steering committee for major international clinical trials in these fields. He gives invited lectures at many international meetings each year
Royal College of Physicians
British Cardiac Society
British Cardiovascular Intervention Society
Loading
Yes, but only for certain services. Some consultations, assessments, and treatments can be booked directly, while others require a GP or specialist referral. Please check the relevant service page for guidance, and contact the centre if you’re unsure.
We aim to offer appointments as quickly as possible, and many services have same-day or next-day availability. Waiting times vary depending on the appointment type, specialty, and consultant availability, but our team will always offer the earliest suitable appointment.
Yes. You can arrange an appointment for a family member, or someone you care for, just let us know when you get in touch. We’ll need their details and consent to complete the booking, unless you're their legal guardian or have power of attorney.
Your first consultation includes a detailed discussion of your symptoms, medical history, and lifestyle factors, followed by a thorough examination. It’s helpful if you can bring the results of any previous investigations with you, as well as a list of your current medications. Come with a comfortably full bladder so you can provide a urine sample if requested.
Inclisiran is a new cholesterol-lowering drug, the first of a class of treatments using RNA interference to boost the liver’s ability to remove harmful cholesterol. Dr Iqbal Malik takes a closer look at cholesterol and the efficacy of Inclisiran.
Welbeck present a series of webinars hosted by our Welbeck Consultants across various specialities.
Dr Malik says “alcohol is a potent driver for atrial fibrillation (AF) and cutting back reduces the risk of it coming back. This article in the NEJM provides more evidence for this”.